Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer In

Affiliation auteurs!!!! Error affiliation !!!!
TitreCirculating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer In
Type de publicationJournal Article
Year of Publication2017
AuteursPierga J-Y, Tredant O., Chevrier M., Dubot C., Lorgis V., Romieu G., Goncalves A., Debled M., Levy C., Ferrero J-M, Jouannaud C., Luporsi E., Mouret-Reynier M-A, Dalenc F., Berger F., Lemonnier J., Proudhon C., Bidard F-C
JournalCANCER RESEARCH
Volume77
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS16-P1-01-02